16 results
DEFR14A
ketsxwi1 zb
5 May 21
Revised proxy
4:16pm
8-K
EX-99.1
3hh8w8jak9 8r
21 Feb 12
Conference Call Today 10 a.m. EST
12:00am
8-K
EX-99.1
45dgy aww9jf8mhs95
20 Dec 11
Repligen Completes Acquisition of Novozymes Biopharma Sweden AB
12:00am
8-K
EX-99.2
szhka1gf n3
28 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
md878g
28 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
vsch6z 5bcvohtjsa
27 Oct 11
Vice President, Market Development
12:00am
8-K
EX-99.1
b6ys ku9s
25 Aug 09
Repligen Elects Glenn L. Cooper, M.D. to the Board of Directors
12:00am
8-K
EX-99.1
6nx nyoxg
11 Jun 09
Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
12:00am
8-K
EX-99.1
4cf0ww8fmf0bgya 2cx
27 Jul 05
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
0as3a
6 Oct 99
Current report
12:00am
- Prev
- 1
- Next